EUVIMEDEUVIMED entdecken
Crossref

In vitro, in vivo, and in silico evaluation of the glucocorticoid receptor antagonist activity of 3,6-dibromocarbazole

Haoyang Zou, Jia Yu, Zhuolin Li, Yao Liu, Tuoyi Wang, Tiezhu Li, Chengyu Lv, Jie Zhang

Food and Chemical Toxicology · 2023

DOI: 10.1016/j.fct.2023.114048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2023. Verfasst von Haoyang Zou und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Engineering, Jilin University, Changchun, 130062, China. Hauptthemen laut MEDLINE: Receptors, Glucocorticoid, Carbazoles, Endocrine Disruptors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

3,6-Dibromocarbazole is a novel environmental contaminant which is currently detected in several environmental media worldwide. This work aims to investigate the anti-glucocorticoid potency and endocrine disrupting effects of 3,6-dibromocarbazole. In vitro experiments indicated that 3,6-dibromocarbazole possessed glucocorticoid receptor (GR) antagonistic activity and inhibited dexamethasone-induced GR nuclear translocation. 3,6-Dibromocarbazole reduced the expression levels of glucocorticoid responsive genes including glucose-6-phosphatase (G6Pase), phosphoenolpyruvate carboxykinase (PEPCK), fatty acid synthase (FAS), and tyrosine aminotransferase (TAT), and further disrupted the protein expression of two key enzymes PEPCK and FAS in gluconeogenesis. In vivo experiments showed that 3,6-dibromocarbazole induced abnormal development of zebrafish embryos and disrupted the major neurohormones involved in activation of hypothalamic-pituitary-adrenocortical (HPA) axis in zebrafish larvae. The results of molecular docking and molecular dynamics simulation contributed to explain the antagonistic effect of 3,6-dibromocarbazole. Taken together, this work identified 3,6-dibromocarbazole as a GR antagonist, which might exert endocrine disrupting effects by interfering the pathway of gluconeogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, GlucocorticoidCarbazolesEndocrine DisruptorsAnimalsZebrafishMolecular Docking SimulationMolecular Dynamics SimulationGluconeogenesisHypothalamo-Hypophyseal SystemHumans

Stichwörter der Autor:innen

3,6-DibromocarbazoleAntagonist activityGlucocorticoid receptorZebrafish

Substanzen

Receptors, GlucocorticoidCarbazolesEndocrine Disruptors

Autor:innen und Institutionen

  • College of Food Science and Engineering, Jilin University, Changchun, 130062, China.
  • Institute of Agro-food Technology, Jilin Academy of Agricultural Sciences, Changchun, 130033, China.
  • College of Food and Bioengineering, Qiqihar University, Qiqihar, 161006, China.
  • College of Food Science and Engineering, Jilin University, Changchun, 130062, China. Electronic address: zhangjie83@jlu.edu.cn.

Zitieren

APA

Zou, H., Yu, J., Li, Z., Liu, Y., Wang, T., Li, T., Lv, C., & Zhang, J. (2023). In vitro, in vivo, and in silico evaluation of the glucocorticoid receptor antagonist activity of 3,6-dibromocarbazole. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2023.114048

Vancouver

Zou H, Yu J, Li Z, Liu Y, Wang T, Li T, et al. In vitro, in vivo, and in silico evaluation of the glucocorticoid receptor antagonist activity of 3,6-dibromocarbazole. Food and Chemical Toxicology. 2023. doi:10.1016/j.fct.2023.114048

BibTeX
@article{Zou2023,
  author = {Zou, Haoyang and Yu, Jia and Li, Zhuolin and Liu, Yao and Wang, Tuoyi and Li, Tiezhu and Lv, Chengyu and Zhang, Jie},
  title = {In vitro, in vivo, and in silico evaluation of the glucocorticoid receptor antagonist activity of 3,6-dibromocarbazole},
  journal = {Food and Chemical Toxicology},
  year = {2023},
  doi = {10.1016/j.fct.2023.114048}
}
Kostenlos starten →